EODData

NASDAQ, NTLA: Intellia Thera CS

17 Jul 26 15:59
LAST:

11.37

CHANGE:
 0.49
OPEN:
11.80
HIGH:
11.92
ASK:
23.56
VOLUME:
2.96M
CHG(%):
4.09
PREV:
11.86
LOW:
11.35
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Jul 2611.7311.8411.3511.384.33M
16 Jul 2612.4312.5911.6511.866.53M
15 Jul 2613.1313.3812.8813.044.03M
14 Jul 2613.3113.5713.0013.304.05M
13 Jul 2613.7613.7712.7713.027.48M
10 Jul 2615.4415.4414.1014.226.18M
09 Jul 2616.5917.1615.1515.447.39M
08 Jul 2616.8117.0916.3516.843.55M
07 Jul 2617.8518.1116.8517.433.17M
06 Jul 2617.3318.0816.1717.843.85M

PROFILE

Name:Intellia Thera CS
About:Intellia Therapeutics, Inc., a clinical-stage gene editing company, focuses on the development of curative genome editing treatments. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 that is in Phase 1/2 study for the treatment of hereditary angioedema. It also focusses on the research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. The company has license and collaboration agreement with AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of various of B cell-mediated autoimmune diseases; ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer; and ReCode Therapeutics, Inc. to develop novel genomic medicines for the treatment of cystic fibrosis. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:40 Erie Street, Cambridge, MA, United States, 02139
Website:https://www.intelliatx.com
CUSIP:45826J105
CIK:0001652130
ISIN:US45826J1051
FIGI:BBG007KC7PB0
LEI:5493002T5BCPE5DZC723

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-2.49 
Forward P/E:-9.97 
PEG Ratio:0.07 
Price to Sales:25.63 
Price to Book:3.31 
Operating Margin:-7.72 
Return on Assets:-0.31 
Return on Equity:-0.57 
EPS Ratio:-3.52 
Revenue:52.86M 
Shares:139.72M 
Market Cap:1.589B 

TECHNICAL INDICATORS

MA5:12.5210.1%
MA10:14.4427.0%
MA20:15.3835.3%
MA50:14.2024.9%
MA100:13.9322.5%
MA200:13.6119.7%
RSI14:18.14 
WPR14:-100.00 
MTM14:-5.24
ROC14:-0.32 
ATR:1.18 
Week High:15.4435.8%
Week Low:11.350.2%
Month High:18.4862.5%
Month Low:11.3519.7%
Year High:28.25148.5%
Year Low:7.9543.0%
Volatility:20.24